Investor Name	Invest Money	Lead Investor	Propotion
Lux Capital	-	Yes	-	Detail
Pharmaceutical Product Development	-	Yes	-	Detail
Redmile Group	-	Yes	-	Detail
Amgen	-	-	-	Detail
Glynn Capital Management	-	-	-	Detail
GV	-	-	-	Detail
LifeSci Venture Partners	-	-	-	Detail
Mubadala Capital Ventures	-	-	-	Detail
Novartis	-	-	-	Detail
Sanofi Ventures	-	-	-	Detail

Announced Date	Round	Money Raised	Investors
Jan 3, 2019	Series D	$ 35M	dRx Capital,Glynn Capital Management,etc.	Detail
Oct 20, 2015	Series A	$ 6.50M	Arthur Iinuma,dRx Capital,etc.	Detail
Apr 25, 2017	Series C	$ 35M	Amgen Ventures,dRx Capital,etc.	Detail
Oct 18, 2016	Series B	$ 31M	Arthur Iinuma,dRx Capital,etc.	Detail